NCB:F:F-Bank of America Corporation (EUR)

COMMON STOCK | Banks - Diversified |

Last Closing

USD 36.565

Change

+0.06 (+0.15)%

Market Cap

USD 288.74B

Volume

1.41K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Banks - Diversified

Symbol Name Price(Change) Market Cap
CMCI:F JPMORGAN CHASE CO. CDR

+0.20 (+1.13%)

USD 527.31B
CMC:F JPMorgan Chase & Co

-2.08 (-1.13%)

USD 515.75B
NCB0:F BANK OF AMERICA CORP. CDR

+0.30 (+2.21%)

USD 285.70B
ICKB:F IND.+COMM.BK CHINA ADR/20

N/A

USD 237.42B
ICK:F Industrial and Commercial Bank..

+0.01 (+2.19%)

USD 234.95B
EK7A:F AGRICULT.BK H.ADR/25 YC 1

-0.20 (-2.00%)

USD 187.69B
NWT:F Wells Fargo & Company

-0.22 (-0.40%)

USD 186.36B
EK7:F Agricultural Bank of China Lim..

N/A

USD 185.71B
C6TB:F CHINA CON.BANK ADR/20 YC1

N/A

USD 168.94B
C6T:F China Construction Bank Corpor..

N/A

USD 166.03B

ETFs Containing NCB:F

AFRN:PA Amundi Index Solutions - .. 1.82 % 0.00 %

+0.02 (+0.15%)

USD 0.96B
FRNE:F Amundi Index Solutions - .. 1.82 % 0.00 %

N/A

N/A
FRNE:XETRA Amundi Index Solutions - .. 1.82 % 0.00 %

+0.07 (+0.15%)

USD 1.24B
AFRHU:PA Amundi Index Solutions - .. 1.82 % 0.00 %

+0.02 (+0.15%)

N/A
WINC Western Asset Short Durat.. 1.52 % 0.00 %

-0.01 (0.15%)

USD 0.01B
RUSB:CA RBC Short Term U.S. Corpo.. 1.26 % 0.40 %

N/A

CAD 0.25B
UEF7:F UBS ETF - Bloomberg Barcl.. 1.01 % 0.00 %

N/A

USD 0.29B
UEF8:F UBS Barclays US Liquid Co.. 1.01 % 0.00 %

N/A

N/A
UEF8:XETRA UBS Barclays US Liquid Co.. 1.01 % 0.00 %

-0.01 (0.15%)

USD 0.28B
UEF7:XETRA UBS Barclays US Liquid Co.. 1.01 % 0.00 %

+0.04 (+0.15%)

USD 0.25B
CBUS5:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

+0.01 (+0.15%)

USD 0.28B
CBUS5H:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

N/A

USD 0.06B
CBUS5S:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

+0.01 (+0.15%)

USD 0.12B
CBUS5E:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

N/A

USD 0.57B
ESGF:CA BMO ESG US Corporate Bond.. 0.99 % 0.00 %

-0.05 (0.15%)

CAD 0.02B
ZSU:CA BMO Short-Term US IG Corp.. 0.98 % 0.28 %

-0.01 (0.15%)

CAD 0.15B
RUSB-U:CA 0.92 % 0.00 %

N/A

N/A
QUIG:CA Mackenzie US Investment G.. 0.80 % 0.28 %

-0.02 (0.15%)

CAD 0.54B
SUSD:LSE SSgA SPDR ETFs Europe I p.. 0.64 % 0.00 %

+0.15 (+0.15%)

USD 0.20B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.61 % 0.00 %

-0.02 (0.15%)

USD 0.20B
4UBP:XETRA UBS(Lux)Fund Solutions .. 0.58 % 0.00 %

+0.03 (+0.15%)

USD 0.04B
4UBR:XETRA UBS(Lux)Fund Solutions .. 0.58 % 0.00 %

N/A

USD 0.03B
CORPS:SW UBS(Lux)Fund Solutions .. 0.58 % 0.00 %

N/A

USD 9.43M
UET0:F UBS (Lux) Fund Solutions .. 0.57 % 0.00 %

-0.03 (0.15%)

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

-0.02 (0.15%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

N/A

USD 0.03B
CBSUS:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

N/A

USD 0.19B
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

N/A

USD 0.21B
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

N/A

USD 0.05B
UC76:LSE UBS Barclays US Liquid Co.. 0.54 % 0.00 %

-0.01 (0.15%)

USD 0.08B
UC85:LSE UBS Barclays US Liquid Co.. 0.54 % 0.00 %

-1.00 (0.15%)

USD 0.06B
UEF0:F UBS Barclays US Liquid Co.. 0.52 % 0.00 %

-0.01 (0.15%)

USD 0.18B
UEF9:F UBS Barclays US Liquid Co.. 0.52 % 0.00 %

+0.01 (+0.15%)

USD 0.08B
UEF0:XETRA UBS Barclays US Liquid Co.. 0.52 % 0.00 %

-0.01 (0.15%)

USD 0.36B
UEF9:XETRA UBS Barclays US Liquid Co.. 0.52 % 0.00 %

+0.04 (+0.15%)

USD 0.08B
CBUSH:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

N/A

USD 0.06B
CBUSS:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

N/A

USD 0.03B
CBUSE:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

N/A

USD 0.18B
CBUS:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

+0.01 (+0.15%)

USD 0.08B
CBUSAC:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

N/A

USD 0.10B
ZIC-U:CA BMO Mid-Term US IG Corpor.. 0.48 % 0.00 %

N/A

N/A
ZIC:CA BMO Mid-Term US IG Corpor.. 0.48 % 0.26 %

+0.01 (+0.15%)

CAD 2.91B
UCRP:XETRA Amundi Index Solutions - .. 0.36 % 0.00 %

+0.11 (+0.15%)

N/A
UCRP:F Amundi Index Solutions - .. 0.36 % 0.00 %

+0.16 (+0.15%)

N/A
UCRP:PA Amundi Index Solutions - .. 0.36 % 0.00 %

-0.09 (0.15%)

N/A
UCRH:XETRA Amundi Index Solutions - .. 0.36 % 0.00 %

+0.01 (+0.15%)

USD 0.35B
SEUC:PA SSgA SPDR ETFs Europe I p.. 0.35 % 0.00 %

+0.02 (+0.15%)

USD 1.26B
SYBD:F SSgA SPDR ETFs Europe I p.. 0.35 % 0.00 %

+0.02 (+0.15%)

USD 1.26B
SYBF:F SSgA SPDR ETFs Europe I p.. 0.35 % 0.00 %

+0.06 (+0.15%)

USD 0.19B
SYBD:XETRA SPDR® Bloomberg 0-3 Year.. 0.35 % 0.00 %

-0.01 (0.15%)

USD 1.27B
SYBF:XETRA SPDR Barclays 0-3 Year US.. 0.35 % 0.00 %

+0.14 (+0.15%)

USD 0.19B
SUSC:SW SPDR® Bloomberg 0-3 Year.. 0.35 % 0.00 %

+0.17 (+0.15%)

USD 0.20B
SEUC:SW SPDR® Bloomberg 0-3 Year.. 0.35 % 0.00 %

+0.04 (+0.15%)

USD 1.26B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.31 % 0.00 %

+0.05 (+0.15%)

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.31 % 0.00 %

+0.11 (+0.15%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.31 % 0.00 %

N/A

USD 0.27B
PR1P:XETRA Amundi Index Solutions - .. 0.28 % 0.00 %

+0.04 (+0.15%)

USD 0.10B
PRAP:XETRA Amundi Index Solutions - .. 0.28 % 0.00 %

+0.05 (+0.15%)

USD 0.09B
PR1P:F Amundi Index Solutions - .. 0.28 % 0.00 %

+0.01 (+0.15%)

USD 0.10B
PRAP:F Amundi Index Solutions Si.. 0.28 % 0.00 %

+0.04 (+0.15%)

USD 0.09B
EUCO:PA SPDR Barclays Euro Corpor.. 0.20 % 0.00 %

+0.08 (+0.15%)

USD 0.78B
SYBC:F SSgA SPDR ETFs Europe I P.. 0.20 % 0.00 %

N/A

USD 0.80B
SYBC:XETRA SPDR Barclays Euro Corpor.. 0.20 % 0.00 %

+0.09 (+0.15%)

USD 0.78B
ECRP:PA Amundi Index Solutions - .. 0.18 % 0.00 %

+0.02 (+0.15%)

USD 3.58B
DECR:F Amundi Index Solutions - .. 0.18 % 0.00 %

+0.04 (+0.15%)

USD 0.91B
DECR:XETRA Amundi Index Solutions - .. 0.18 % 0.00 %

+0.08 (+0.15%)

USD 0.17B
A4H8:XETRA Amundi Index Solutions - .. 0.18 % 0.00 %

+0.04 (+0.15%)

USD 5.34B
EUCO:LSE SPDR Barclays Euro Corpor.. 0.17 % 0.00 %

-0.01 (0.15%)

USD 0.79B

Market Performance

  Market Performance vs. Industry/Classification (Banks - Diversified) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.42% 69% C- 80% B-
Dividend Return 1.57% 9% A- 31% F
Total Return 20.98% 63% D 74% C
Trailing 12 Months  
Capital Gain 35.73% 80% B- 85% B
Dividend Return 3.56% 9% A- 38% F
Total Return 39.29% 59% D- 79% B-
Trailing 5 Years  
Capital Gain 47.14% 69% C- 68% D+
Dividend Return 10.30% 18% F 40% F
Total Return 57.44% 45% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.44% 46% F 65% D
Dividend Return 8.14% 31% F 63% D
Total Return 1.69% 37% F 52% F
Risk Return Profile  
Volatility (Standard Deviation) 25.74% 56% F 48% F
Risk Adjusted Return 31.61% 30% F 60% D-
Market Capitalization 288.74B 96% N/A 100% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector